Yonghe Medical Group Co (STU:L97) 10-Year RORE % : 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:L97 Yonghe Medical Group Co Ltd STU:L97
84 GF Score
Price €0.25
GF Value €0.20
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co 10-Year RORE %?

Yonghe Medical Group Co STU:L97 -5.97% 84 10-Year RORE % is 0.00 as of Jun. 2026. GuruFocus rates STU:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.20. The stock has 7 warning signs investors should review. Among 323 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks worse than 309597.21% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Yonghe Medical Group Co does not have enough data to calculate 10-Year RORE %.


Yonghe Medical Group Co  (STU:L97) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Yonghe Medical Group Co 10-Year RORE % Related Terms


Yonghe Medical Group Co 10-Year RORE % Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co 10-Year RORE % Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
10-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:L97 vs HCA, THC, DVA: 10-Year RORE % Comparison

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co 10-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's 10-Year RORE % falls into.


STU:L97
84GF Score
Yonghe Medical Group Co Ltd STU:L97
10-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co 10-Year RORE % Calculation

Yonghe Medical Group Co's 10-Year RORE % for the quarter that ended in Jun. 2026 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 10-year before.

Frequently Asked Questions Learn more about 10-Year RORE % →
What does a 10-Year RORE % of 0.00 mean?
Yonghe Medical Group Co (STU:L97) has a 10-Year RORE % of 0.00 as of Jun. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Yonghe Medical Group Co and its competitors. According to the industry distribution chart, Yonghe Medical Group Co ranks #999999 out of 323 companies in the Healthcare Providers & Services industry.
Is Yonghe Medical Group Co's 10-Year RORE % too high?
Yonghe Medical Group Co's current 10-Year RORE % is 0.00. Based on the distribution chart, Yonghe Medical Group Co ranks #999999 out of 323 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's 10-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #999999 out of 323 companies for 10-Year RORE %. This places Yonghe Medical Group Co in the lower half of its industry. The industry median 10-Year RORE % is 6.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 6.98, based on 323 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 6.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current 10-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (STU:L97) has a current 10-Year RORE % of 0.00. The stock's GF Value™ is €0.20, compared to a current price of €0.25 — trading 26% above its estimated fair value. The current 10-Year RORE % is 0.00. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Yonghe Medical Group Co (STU:L97), the current 10-Year RORE % is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (STU:L97) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of €0.25 is trading 26% above its estimated GF Value™ of €0.20.

Key valuation signals for STU:L97:

  • 10-Year RORE %: 0.00
  • GF Value™: €0.20 vs. price of €0.25 (26% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the STU:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yonghe Medical Group Co Business Description

Other Exchanges 02279:Hong KongL97:Germany
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for STU:L97

10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.20
GF Value